CRL vs MCB · rev $2.00B vs P/E 13, rev $5.2M
Charles River Laboratories (CRL) versus Metropolitan Bank Holding (MCB) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Metropolitan Bank Holding (MCB) is a banks - regional company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MCB revenue for 2026-06-30 was $5.2M. Net income was $50.6M. Revenue was up 99.1% from 2026-03-31 to 2026-06-30. MCB currently screens at market cap $798.5M and trailing P/E 12.7.
CRL currently screens at market cap $7.78B. MCB currently screens at market cap $798.5M and trailing P/E 12.7.
Not investment advice. Open the CRL and MCB stock pages for the full models.
Not investment advice.